Trial Profile
A 6-Week Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Safety and Efficacy Study of the Potential Inhibitory Effects on the Hypothalamic-Pituitary-Adrenal Axis of Ciclesonide HFA Nasal Aerosol and Ciclesonide Aqueous Nasal Spray in Subjects 12 Years and Older With Perennial Allergic Rhinitis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Aug 2023
Price :
$35
*
At a glance
- Drugs Ciclesonide (Primary) ; Dexamethasone
- Indications Perennial allergic rhinitis
- Focus Adverse reactions
- 08 Nov 2011 Results presented at the 2011 Annual Meeting of the American College of Allergy, Asthma and Immunology.
- 19 May 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Feb 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.